Business Description
Adocia
ISIN : FR0011184241
Total Employee Number:
82Compare
Compare
Traded in other countries / regions
ADOC.FranceA89.Germany0QAI.UKADOCY.USA IPO Date
2016-04-08Description
Adocia is a clinical-stage biotechnology company focused on developing treatments for diabetes, obesity, and related metabolic diseases. The company uses its proprietary BioChaperone, AdoShell, AdOral and AdoXLong technology platforms to develop improved formulations of therapeutic proteins and peptides, oral and long-acting metabolic treatments, and immunoprotective cell-therapy solutions. Its pipeline includes BioChaperone Lispro, BioChaperone GLP-1 Amylin, AdoXLong Sema, AdOral Sema, AdoShell Islets and M1Pram.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.94 | |||||
Equity-to-Asset | 0.05 | |||||
Debt-to-Equity | 5.97 | |||||
Debt-to-EBITDA | -0.58 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.71 | |||||
Beneish M-Score | -5.14 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -61.4 | |||||
3-Year EBITDA Growth Rate | -24.5 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
3-Year FCF Growth Rate | 41.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | -76.78 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 184.24 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 58.41 | |||||
9-Day RSI | 55.12 | |||||
14-Day RSI | 50.87 | |||||
3-1 Month Momentum % | -13.11 | |||||
6-1 Month Momentum % | -34.77 | |||||
12-1 Month Momentum % | -35.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.19 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.86 | |||||
Days Inventory | 124.74 | |||||
Days Sales Outstanding | 4213.11 | |||||
Days Payable | 681.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.1 | |||||
Shareholder Yield % | -23.59 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 17.25 | |||||
Operating Margin % | -3236.76 | |||||
Net Margin % | -3406.78 | |||||
EBITDA Margin % | -3155.44 | |||||
FCF Margin % | -1395.69 | |||||
OCF Margin % | -1340.86 | |||||
ROA % | -60.18 | |||||
ROIC % | -72.1 | |||||
3-Year ROIIC % | 631.97 | |||||
ROC (Joel Greenblatt) % | -504 | |||||
ROCE % | -216.57 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 25.47 | |||||
PS Ratio | 150.64 | |||||
PB Ratio | 51.55 | |||||
Price-to-Tangible-Book | 50 | |||||
EV-to-EBIT | -4.57 | |||||
EV-to-EBITDA | -4.72 | |||||
EV-to-Revenue | 149.39 | |||||
EV-to-Forward-Revenue | 1709.72 | |||||
EV-to-FCF | -10.25 | |||||
Price-to-GF-Value | 4.6 | |||||
Price-to-Median-PS-Value | 5 | |||||
Earnings Yield (Greenblatt) % | -21.81 | |||||
FCF Yield % | -8.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adocia Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.487 | ||
| EPS (TTM) (€) | -0.9 | ||
| Beta | 0.395 | ||
| 3-Year Sharpe Ratio | 0.2 | ||
| 3-Year Sortino Ratio | 0.45 | ||
| Volatility % | 50.68 | ||
| 14-Day RSI | 50.87 | ||
| 14-Day ATR (€) | 0.084637 | ||
| 20-Day SMA (€) | 3.877 | ||
| 12-1 Month Momentum % | -35.47 | ||
| 52-Week Range (€) | 3.69 - 12.24 | ||
| Shares Outstanding (Mil) | 20.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Adocia Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Adocia Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Adocia Frequently Asked Questions
What is Adocia(LTS:0QAI)'s stock price today?
The current price of LTS:0QAI is €4.00. The 52 week high of LTS:0QAI is €12.24 and 52 week low is €3.69.
When is next earnings date of Adocia(LTS:0QAI)?
The next earnings date of Adocia(LTS:0QAI) is .
Does Adocia(LTS:0QAI) pay dividends? If so, how much?
Adocia(LTS:0QAI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Adocia
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers